Antipsychotic Effects of Oxytocin

Trial Profile

Antipsychotic Effects of Oxytocin

Phase of Trial: Phase II

Latest Information Update: 18 Jan 2017

At a glance

  • Drugs Oxytocin (Primary)
  • Indications Schizophrenia
  • Focus Therapeutic Use
  • Sponsors Retrophin
  • Most Recent Events

    • 11 Jan 2017 Planned End Date changed from 1 Dec 2016 to 1 Dec 2018.
    • 11 Jan 2017 Planned primary completion date changed from 1 Dec 2016 to 1 Dec 2018.
    • 12 Dec 2016 Planned End Date changed from 1 Aug 2014 to 1 Dec 2016.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top